Clinical Studies & Resources

Salonpas® allocates significant resources to clinical study and product innovation that keeps us aligned to the needs of pain sufferers and the professional guidance that recommends a “topicals first” approach to pain management.

Clinical Studies of Salonpas® Products

Higashi Study

From a randomized, double-blind, parallel-group, placebo-controlled, multicenter study forming the basis of our New Drug Application approval.

Learn more


Observational study of benefits of Salonpas® Pain Relieving Patch on pain intensity, use of concurrent oral medications and BPI scores.

Learn more
Box of Salonpas Pain Relieving Patches with Maxtrix-like backdrop

AI Study

Applying artificial intelligence (AI) to patient profile reveals which ones could benefit most from Salonpas®.

Learn more

Treatment Guidelines

missing image


In response to the opioid crisis, the CDC released importance guidance for the use of topical analgesics as first line medicine.

Learn more


These two academies released guidance that recommends a “topical NSAIDs first approach” for acute non-low back musculoskeletal pain.

Learn more

Additional Information on Topical Analgesics

Dr. Gudin

Dr. Gudin Q&A

Esteemed doctor and Salonpas® Advisor shares his insights.

Learn more
Salonpas Pain Relief Patch products

#1 Doctor Recommended

If you’re recommending Salonpas® to your patients, you’re in good company.

Learn more